European Nanomedicine Characterization Laboratory

Projektinformationen

EUNCL

ID Finanzhilfevereinbarung: 654190

DOI

10.3030/654190

Projekt abgeschlossen

EK-Unterschriftsdatum 26 Juni 2015

Startdatum 1 Mai 2015

Enddatum 31 Dezember 2019

Finanziert unter

• EXCELLENT SCIENCE - Research Infrastructures

Gesamtkosten

€ 5 627 303,50

EU-Beitrag

€ 4 995 181,00

Koordiniert durch

COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
France

CORDIS bietet Links zu öffentlichen Ergebnissen und Veröffentlichungen von HORIZONT-Projekten.

Links zu Ergebnissen und Veröffentlichungen von RP7-Projekten sowie Links zu einigen Typen spezifischer Ergebnisse wie Datensätzen und Software werden dynamisch von OpenAIRE abgerufen.

Leistungen

Documents, reports (27)

Liaison activities with external stakeholders –final report

A final report on the Liaison activities with external stakeholders will be prepared.

1st scientific report on Structure Activity Relationship studies
2nd report on reviews of QMS of EU-NCL
2nd scientific report on mode of action studies
Liaison activities with external stakeholders – 1st report
2nd Prioritized list of candidate technologies
3rd report on reviews of QMS of EU-NCL
1st completed survey with regulatory bodies
Activities to promote innovation through partnership with industry– 3rd report
2nd Completed survey with regulatory bodies
1st report on reviews of QMS of EU-NCL
CMS implemented
1st Data management plan
1st List of candidate technologies
2nd Data management plan
2nd report on the testing and optimization of novel technologies
1st report on modeling of analytical decision process
3rd Completed survey with regulatory bodies
3rd Data Management Plan

3rd Sample Management Report

1st report on the testing and optimization of novel technologies
Activities to promote innovation through partnership with industry – 2nd report

Activities to promote innovation through partnership with industry– 2nd report

Activities to promote innovation through partnership with industry– 1st report
2nd List of candidate technologies
2nd scientific report on Structure Activity Relationship studies
1st Prioritized list of candidate technologies
1st scientific report on mode of action studies
2nd report on modeling of analytical decision process

Websites, patent fillings, videos etc. (9)

Publication of 2nd TNA open call
EU-NCL annual workshop –year 3
Publication of 1st TNA open call
Publication of “State-of-the-art” manuscript – version 1
EU-NCL annual workshop –year 2
Publication of “State-of-the-art” manuscript – version 2
EU-NCL annual workshop – year 4
EU-NCL website
Publication of 3rd TNA open call

Demonstrators, pilots, prototypes (5)

3rd Collection of approved measurement SOPs
2nd Collection of approved measurement SOPs
1st Collection of approved measurement SOPs
Sample receiving laboratory installed
4th Collection of approved measurement SOPs

Other (3)

TNA “guide for applicant” & evaluation form
CMS developed
Appointment of the peer review evaluation board

Veröffentlichungen

Peer reviewed articles (6)

Analytical ultracentrifugation for analysis of doxorubicin loaded liposomes

Autoren: Dora Mehn, Patrizia Iavicoli, Noelia Cabaleiro, Sven Even Borgos, Fanny Caputo, Otmar Geiss, Luigi Calzolai, François Rossi, Douglas Gilliland
Veröffentlicht in: International Journal of Pharmaceutics, Ausgabe 523/1, 2017, Seite(n) 320-326, ISSN 0378-5173
Herausgeber: Elsevier BV
DOI: 10.1016/j.ijpharm.2017.03.046

Measuring Particle Size Distribution by Asymmetric Flow Field Flow Fractionation: A Powerful Method for the Preclinical Characterization of Lipid-Based Nanoparticles

Autoren: Fanny Caputo, Amandine Arnould, Maria Bacia, Wai Li Ling, Emilie Rustique, Isabelle Texier, Adriele Prina Mello, Anne-Claude Couffin
Veröffentlicht in: Molecular Pharmaceutics, Ausgabe 16/2, 2018, Seite(n) 756-767, ISSN 1543-8384
Herausgeber: American Chemical Society
DOI: 10.1021/acs.molpharmaceut.8b01033

Are existing standard methods suitable for the evaluation of nanomedicines: some case studies

Autoren: Sabrina Gioria, Fanny Caputo, Patricia Urbán, Ciarán Manus Maguire, Susanne Bremer-Hoffmann, Adriele Prina-Mello, Luigi Calzolai, Dora Mehn
Veröffentlicht in: Nanomedicine, Ausgabe 13/5, 2018, Seite(n) 539-554, ISSN 1743-5889
Herausgeber: Future Medicine Ltd.
DOI: 10.2217/nnm-2017-0338

Larger or more? Nanoparticle characterisation methods for recognition of dimers

Autoren: D. Mehn, F. Caputo, M. Rösslein, L. Calzolai, F. Saint-Antonin, T. Courant, P. Wick, D. Gilliland
Veröffentlicht in: RSC Advances, Ausgabe 7/44, 2017, Seite(n) 27747-27754, ISSN 2046-2069
Herausgeber: Royal Society of Chemistry
DOI: 10.1039/c7ra02432k

Measuring particle size distribution of nanoparticle enabled medicinal products, the joint view of EUNCL and NCI-NCL. A step by step approach combining orthogonal measurements with increasing complexity

Autoren: F. Caputo, J. Clogston, L. Calzolai, M. Rösslein, A. Prina-Mello
Veröffentlicht in: Journal of Controlled Release, Ausgabe 299, 2019, Seite(n) 31-43, ISSN 0168-3659
Herausgeber: Elsevier BV
DOI: 10.1016/j.jconrel.2019.02.030

Sound understanding of environmental, health and safety, clinical, and market aspects is imperative to clinical translation of nanomedicines

Autoren: Matthias Rösslein, Neill J. Liptrott, Andrew Owen, Patrick Boisseau, Peter Wick, Inge K. Herrmann
Veröffentlicht in: Nanotoxicology, Ausgabe 11/2, 2017, Seite(n) 147-149, ISSN 1743-5390
Herausgeber: Informa Healthcare
DOI: 10.1080/17435390.2017.1279361

Book chapters (1)

Multiparametric Preclinical Assessment of Theranostics Materials

Autoren: Adriele Prina-Mello
Veröffentlicht in: Handbook of Nanomaterials for Cancer Theranostics, 2018, Seite(n) 517-535, ISBN 9780-128133392
Herausgeber: Elsevier
DOI: 10.1016/b978-0-12-813339-2.00017-7